Dr. Avi Spier, Executive Director Business Development and Licensing at Novartis, on how to find successful partnerships. "The collaborations we create are the key to our company's success," said Dr.
Avi Spier, Executive Director Business Development and Licensing at Novartis, speaking at the Novartis-Israel Health Innovation Meetup. As part of his responsibilities, Spier scouts Novartis’s next investments. As he puts it, he focuses mainly on the way such collaborations are created, and his tips cut across industries.
RELATED ARTICLES The exec who decides which drugs Novartis will develop "We seek star researchers, pioneers in their fields" Startup Nation Central data reveal the opportunities "We want to be a bridge between Israel and the world" First, he says, there is no escaping face-to-face meetings, and formal meetings are sometimes not enough. "Let's say, the presentation ends and it doesn’t exactly fit. So, both the presentation and the opportunity are finished with.
But in a conversation, in a meeting, even if an idea seems not to fit one goal, you can talk about other goals. The conversation allows for more opportunities." Spier says that at events and meetings, and in unplanned conversations, Novartis has been able to identify several leading companies for investment.
"Over the years, I've learned that sometimes there are people who talk loudly but don't actually say anything, and by contrast, there are people who say very important things but very quietly. The .